CD 169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
CD 169 (sialoadhesin) is a sialic acid receptor that is expressed on specific macrophages such as lymph node sinus macrophages. Animal studies have suggested that CD 169+ macrophages have a pro‐inflammatory property, however, the role of these cells in human diseases has not been clarified. In our in vitro experiments with human macrophages, pro‐inflammatory cytokines, such as type 1 interferon, induced strong expression of CD 169, suggesting that CD 169 might be a specific marker of inflammatory macrophages. To examine the role of CD 169 in antitumor immunity, we examined the expression of CD 169 in regional lymph nodes (RLN s) and its association with overall survival in colorectal carcinoma (CRC). In a clinicopathological analysis on 83 CRC patients, paraffin‐embedded specimens were evaluated for CD 169 expression of RLN macrophages by immunohistochemistry. We found, for the first time, a high density of CD 169+ macrophages was significantly associated with longer overall survival; multivariate analysis showed that the ratio of CD 169+ cells to CD 68+ cells was an independent prognostic factor. The majority of CD 169+ macrophages were in direct contact with CD 8+ T cells expressing CD 43, a major ligand of CD 169. We also found that the density of CD 169+ macrophages had a positive correlation with the number of CD 8+ cytotoxic T cells infiltrating tumor tissues. These data suggest that CD 169+ macrophages in RLN s promote CD 8+ T‐cell‐mediated antitumor immunity and are associated with a better prognosis for CRC patients. CD 169+ macrophages in RLN s could be a useful marker for assessing clinical prognosis and monitoring antitumor immunity in patients with CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Self-citationSharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611618104 · Cited by 526
Guidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macrì, E., Lanza, G., Boiocchi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61695-1 · Cited by 322
Cited by
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J. H., Zanotelli, V. R. T., Silina, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,004
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
Exosome-Based Cell-Cell Communication in the Tumor Microenvironment
Maia, J., Caja, S., Strano Moraes, M. C., Couto, N., & Costa-Silva, B. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00018 · Cited by 666
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Altered Tumor-Cell Glycosylation Promotes Metastasis
Häuselmann, I., & Borsig, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00028 · Cited by 382
Metadata
- Authors
- Ohnishi, K., Komohara, Y., Saito, Y., Miyamoto, Y., Watanabe, M., Baba, H., & Takeya, M.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2013-07-09
- Volume
- 104
- Issue
- 9
- Pages
- 1237-1244
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2023880559
- Cited by
- 123
- References
- 4
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD 169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. https://app.cochat.ai/papers/10.1111/cas.12212
- The paper
- Ohnishi, K., Komohara, Y., Saito, Y., Miyamoto, Y., Watanabe, M., Baba, H., & Takeya, M. (2013). CD 169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Science. https://doi.org/10.1111/cas.12212
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.